Establishment of a gnotobiotic pig model of Clostridioides difficile infection and disease.
Mahsoub, Hassan M
MetadataShow full item record
AbstractClostridioides difficile (C. difficile) is a gram-positive, spore-forming, anaerobic bacterium known to be the most common cause of hospital-acquired and antibiotic-associated diarrhea. C. difficile infection rates are on the rise worldwide and treatment options are limited, indicating a clear need for novel therapeutics. Gnotobiotic piglets are an excellent model to reproduce the acute pseudomembranous colitis (PMC) caused by C. difficile due to their physiological similarities to humans and high susceptibility to infection. Here, we established a gnotobiotic pig model of C. difficile infection and disease using a hypervirulent strain. C. difficile-infected pigs displayed classic signs of C. difficile infection, including severe diarrhea and weight loss. Inoculated pigs had severe gross and microscopic intestinal lesions. C. difficile infection caused an increase in pro-inflammatory cytokines in samples of serum, large intestinal contents, and pleural effusion. C. difficile spores and toxins were detected in the feces of inoculated animals as tested by anaerobic culture and cytotoxicity assays. Successful establishment of this model is key for future work as therapeutics can be evaluated in an environment that accurately mimics what happens in humans. The model is especially suitable for evaluating potential prophylactics and therapeutics, including vaccines and passive immune strategies.
Data AvailibilityAll data are included in this manuscript.
Rights/Terms© 2022. The Author(s).
KeywordClostridioides difficile infection/illness (CDI)
Pseudomembranous colitis (PMC)
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19108
- Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.
- Authors: Wang S, Heuler J, Wickramage I, Sun X
- Issue date: 2022 Apr 27
- Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
- Authors: Castro-Córdova P, Díaz-Yáñez F, Muñoz-Miralles J, Gil F, Paredes-Sabja D
- Issue date: 2020 Apr
- New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection.
- Authors: Andersson JA, Peniche AG, Galindo CL, Boonma P, Sha J, Luna RA, Savidge TC, Chopra AK, Dann SM
- Issue date: 2020 Mar 10
- Clostridioides difficile spores stimulate inflammatory cytokine responses and induce cytotoxicity in macrophages.
- Authors: Chiu PJ, Rathod J, Hong YP, Tsai PJ, Hung YP, Ko WC, Chen JW, Paredes-Sabja D, Huang IH
- Issue date: 2021 Aug